About Zoetis
Zoetis is the world's largest animal health company, headquartered in Parsippany, New Jersey, developing medicines, vaccines and diagnostics for livestock and companion animals.
Milestones
Milestones as listed on zoetis.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Leadership Team
Leadership as listed on zoetis.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Jay Saccaro
Julie Fuller
Products & Services
Products and services as listed on zoetis.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Apoquel
Dermatology medicine for dogs with allergic skin conditions.
Source: zoetis.comCytopoint
Monoclonal antibody product for dogs listed among Zoetis products.
Source: zoetis.comLibrela
Monoclonal antibody to control osteoarthritis pain in dogs.
Source: zoetis.comPHARMAQ aquaculture vaccines
Vaccines and health products for fish farming, including Alpha Ject for salmon.
Source: zoetis.comSites in Ireland
Tullamore, Co. Offaly
Biopharmaceutical production, including monoclonal antibody therapy for companion animals.
Source: zoetis.comRathdrum, Co. Wicklow
Produces APIs and pharmaceutical products for companion animals.
Source: zoetis.comTallaght, Co. Dublin
Single-product site making teat sealants for dairy farmers worldwide.
Source: zoetis.comSites as listed on zoetis.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Financials & Irish Entities
From the annual reports Zoetis Inc. files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.
| Year to | Revenue | R&D | R&D % | Net income | Filing |
|---|---|---|---|---|---|
| Dec 2025 | $9.47bn | $698m | 7.4% | $2.67bn | 10-K 2026 |
| Dec 2024 | $9.26bn | $686m | 7.4% | $2.49bn | 10-K 2026 |
| Dec 2023 | $8.54bn | $614m | 7.2% | $2.34bn | 10-K 2026 |
| Dec 2022 | $8.08bn | $539m | 6.7% | $2.11bn | 10-K 2025 |
| Dec 2021 | $7.78bn | $508m | 6.5% | $2.04bn | 10-K 2024 |
R&D is shown as tagged in the filing, which for this company can exclude acquired in-process R&D. Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.
Companies registered in Ireland 2 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Zoetis Belgium S.A External company | 908417 | 1950 | — |
| Zoetis Ireland Holding Unlimited Company ULC - Private Unlimited Company | 754151 | 2023 | Dec 2024 |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Zoetis Inc. as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.